IMBiotechnologies Ltd completes purchase of 'Tumor Starvation Technology' from Paladin Labs Inc.
18-Aug-2009 -
IMBiotechnologies Ltd announced that the Company has completed purchase of all assets related to the Occlusin(R) tumor starvation technology from Paladin Labs Inc. In addition to the cash payment provided to purchase the technology, Paladin will receive a one time milestone payment on first sale ...
kidney cancer
liver cancer
medical devices
+3